Search

Howard V. Owens Jr.

Examiner (ID: 6061)

Most Active Art Unit
1623
Art Unit(s)
1623
Total Applications
421
Issued Applications
221
Pending Applications
107
Abandoned Applications
92

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6569065 [patent_doc_number] => 20020165244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Mucin synthesis inhibitors' [patent_app_type] => new [patent_app_number] => 09/920287 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 11479 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165244.pdf [firstpage_image] =>[orig_patent_app_number] => 09920287 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/920287
Mucin synthesis inhibitors Aug 1, 2001 Abandoned
Array ( [id] => 6017631 [patent_doc_number] => 20020103350 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Materials and methods for binding nucleic acids to surfaces' [patent_app_type] => new [patent_app_number] => 09/910697 [patent_app_country] => US [patent_app_date] => 2001-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1670 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103350.pdf [firstpage_image] =>[orig_patent_app_number] => 09910697 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/910697
Materials and methods for binding nucleic acids to surfaces Jul 19, 2001 Issued
Array ( [id] => 6546496 [patent_doc_number] => 20020137780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Differentiating agents for the treatment of inflammatory intestinal diseases' [patent_app_type] => new [patent_app_number] => 09/896984 [patent_app_country] => US [patent_app_date] => 2001-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5130 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137780.pdf [firstpage_image] =>[orig_patent_app_number] => 09896984 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/896984
Differentiating agents for the treatment of inflammatory intestinal diseases Jul 1, 2001 Abandoned
Array ( [id] => 1034541 [patent_doc_number] => 06875751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-05 [patent_title] => '3′-prodrugs of 2′-deoxy-β-L-nucleosides' [patent_app_type] => utility [patent_app_number] => 09/883033 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 24 [patent_no_of_words] => 41373 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/875/06875751.pdf [firstpage_image] =>[orig_patent_app_number] => 09883033 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/883033
3′-prodrugs of 2′-deoxy-β-L-nucleosides Jun 14, 2001 Issued
Array ( [id] => 5802550 [patent_doc_number] => 20020010322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-24 [patent_title] => 'New aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments' [patent_app_type] => new [patent_app_number] => 09/875860 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18416 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20020010322.pdf [firstpage_image] =>[orig_patent_app_number] => 09875860 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/875860
Aromatic derivatives substituted by a ribose, their preparation process and their use as medicaments Jun 6, 2001 Issued
Array ( [id] => 6756353 [patent_doc_number] => 20030004130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Homogeneous pharmaceutical compositions containing zidovudine and lamivudine' [patent_app_type] => new [patent_app_number] => 09/863930 [patent_app_country] => US [patent_app_date] => 2001-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5946 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004130.pdf [firstpage_image] =>[orig_patent_app_number] => 09863930 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/863930
Homogeneous pharmaceutical compositions containing zidovudine and lamivudine May 23, 2001 Abandoned
Array ( [id] => 996614 [patent_doc_number] => 06914054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-07-05 [patent_title] => 'Methods and compositions for treating hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 09/864078 [patent_app_country] => US [patent_app_date] => 2001-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 48866 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/914/06914054.pdf [firstpage_image] =>[orig_patent_app_number] => 09864078 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/864078
Methods and compositions for treating hepatitis C virus May 22, 2001 Issued
Array ( [id] => 1182083 [patent_doc_number] => 06737518 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-18 [patent_title] => 'Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides' [patent_app_type] => B1 [patent_app_number] => 09/700035 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2691 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/737/06737518.pdf [firstpage_image] =>[orig_patent_app_number] => 09700035 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/700035
Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides May 17, 2001 Issued
Array ( [id] => 6082466 [patent_doc_number] => 20020082242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Compositions and methods of double-targeting virus infections and cancer cells' [patent_app_type] => new [patent_app_number] => 09/844201 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18648 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082242.pdf [firstpage_image] =>[orig_patent_app_number] => 09844201 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/844201
Compositions and methods of double-targeting virus infections and cancer cells Apr 26, 2001 Issued
Array ( [id] => 6064134 [patent_doc_number] => 20020032169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue' [patent_app_type] => new [patent_app_number] => 09/834726 [patent_app_country] => US [patent_app_date] => 2001-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7561 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032169.pdf [firstpage_image] =>[orig_patent_app_number] => 09834726 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/834726
Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue Apr 15, 2001 Issued
Array ( [id] => 1271692 [patent_doc_number] => 06653455 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-25 [patent_title] => 'Crystallization of doxorubicin hydrochloride' [patent_app_type] => B1 [patent_app_number] => 09/807451 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4955 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/653/06653455.pdf [firstpage_image] =>[orig_patent_app_number] => 09807451 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/807451
Crystallization of doxorubicin hydrochloride Apr 12, 2001 Issued
Array ( [id] => 6545354 [patent_doc_number] => 20020137725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'Use of tagatose in promoting cardiovascular health' [patent_app_type] => new [patent_app_number] => 09/811654 [patent_app_country] => US [patent_app_date] => 2001-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 438 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137725.pdf [firstpage_image] =>[orig_patent_app_number] => 09811654 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/811654
Use of tagatose in promoting cardiovascular health Mar 19, 2001 Abandoned
Array ( [id] => 6908312 [patent_doc_number] => 20010011079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'Method for large-scale production of di(uridine 5\')-tetraphosphate and salts thereof' [patent_app_type] => new [patent_app_number] => 09/805332 [patent_app_country] => US [patent_app_date] => 2001-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6098 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011079.pdf [firstpage_image] =>[orig_patent_app_number] => 09805332 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/805332
Method for large-scale production of di(uridine 5')-tetraphosphate and salts thereof Mar 11, 2001 Issued
Array ( [id] => 750830 [patent_doc_number] => 07022833 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Process for the preparation of phosphorothioate triesters' [patent_app_type] => utility [patent_app_number] => 10/220353 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6310 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022833.pdf [firstpage_image] =>[orig_patent_app_number] => 10220353 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/220353
Process for the preparation of phosphorothioate triesters Feb 22, 2001 Issued
09/720391 2-(PURIN-9-YL)-TETRAHYDEOFURAN-3,4- DIOL DERIVATIVES Feb 22, 2001 Abandoned
Array ( [id] => 5789594 [patent_doc_number] => 20020161219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Non-enzymatic large scale synthesis of RNA' [patent_app_type] => new [patent_app_number] => 09/790440 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13187 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20020161219.pdf [firstpage_image] =>[orig_patent_app_number] => 09790440 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/790440
Non-enzymatic large scale synthesis of RNA Feb 20, 2001 Abandoned
Array ( [id] => 7079018 [patent_doc_number] => 20010041685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Mucin synthesis inhibitors' [patent_app_type] => new [patent_app_number] => 09/774243 [patent_app_country] => US [patent_app_date] => 2001-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10858 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041685.pdf [firstpage_image] =>[orig_patent_app_number] => 09774243 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/774243
Mucin synthesis inhibitors Jan 30, 2001 Issued
Array ( [id] => 7094037 [patent_doc_number] => 20010034435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Process and equipment for plasmid purification' [patent_app_type] => new [patent_app_number] => 09/774284 [patent_app_country] => US [patent_app_date] => 2001-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8550 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034435.pdf [firstpage_image] =>[orig_patent_app_number] => 09774284 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/774284
Process and equipment for plasmid purification Jan 28, 2001 Issued
Array ( [id] => 1229848 [patent_doc_number] => RE038426 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2004-02-10 [patent_title] => '5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials' [patent_app_type] => E1 [patent_app_number] => 09/772277 [patent_app_country] => US [patent_app_date] => 2001-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2085 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/038/RE038426.pdf [firstpage_image] =>[orig_patent_app_number] => 09772277 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/772277
5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials Jan 28, 2001 Issued
Array ( [id] => 7001193 [patent_doc_number] => 20010053855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'Oligonucleotide protecting groups' [patent_app_type] => new [patent_app_number] => 09/745642 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4995 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053855.pdf [firstpage_image] =>[orig_patent_app_number] => 09745642 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/745642
Oligonucleotide protecting groups Dec 21, 2000 Issued
Menu